Abstract
First, the testing of therapeutic gene vectors in vitro is described. This is followed by a discussion of the administration of therapeutic vectors in vivo. Two methods for assessing the development of anti-tumor immunity after cytokine gene therapy are provided. In addition, two methods for the generation of murine tumor models in syngeneic hostsone subcutaneous and one orthotopicare also included.
Original language | English (US) |
---|---|
Pages (from-to) | Unit 13.5 |
Journal | Current protocols in human genetics / editorial board, Jonathan L. Haines ... [et al.] |
Volume | Chapter 13 |
State | Published - May 2001 |
ASJC Scopus subject areas
- Genetics
- Genetics(clinical)